Back to search
FDAFDA · Food and drugs·Recall number D-0097-2018

Duloxetine Delayed-Release Capsules USP, 30 mg, 30-count bottles, Rx Only, Manufactured for: Lupin Pharmaceuticals, Inc. Baltimore, Maryland 21202 United States, Manufactured by: Lupin Limited Goa 403 722 India, NDC 68180-295-06, UPC 368180295068

Published December 6, 2017 · Recall initiated: November 21, 2017

Summary

FDA records drug Class III recall D-0097-2018, published December 6, 2017 and initiated November 21, 2017. Recalling firm: Lupin Pharmaceuticals Inc.; Status: Terminated; Reported quantity: 111,648 units; Lot: Lot #: G602051, Exp. 12/2017. Class III means the product is not likely to cause adverse health consequences.

Status when published: Terminated — openFDA updates weekly, so this field may not reflect the current status. Always confirm with the official notice.

What's the hazard

Failed Dissolution Specification

What to do

Voluntary: Firm initiated · Letter

Get an email if DULOXETINE has another recall

Free. We only write when there's a new recall that matches. Unsubscribe in one click.

Recall details

Brand
DULOXETINE
Manufacturer
Lupin Pharmaceuticals Inc.
Distributor
Nationwide within the United States
UPC
0368180294030
Lot
Lot #: G602051, Exp. 12/2017
Risk classification
Class III
Area (FDA)
drug
Country
United States

Related recalls

Questions about this recall

Was Duloxetine Delayed-Release Capsules USP, 30 mg, 30-count bottles, Rx Only, Manufactured for: Lupin Pharmaceuticals, Inc. Baltimore, Maryland 21202 United States, Manufactured by: Lupin Limited Goa 403 722 India, NDC 68180-295-06, UPC 368180295068 recalled?

Yes. FDA published recall D-0097-2018 on December 6, 2017. Reported hazard: Failed Dissolution Specification

What should I do if I have this product?

Voluntary: Firm initiated · Letter

How do I know if my unit is part of the recall?

Compare your product details with the notice. Brand: DULOXETINE. UPC: 0368180294030.